Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies

Multiple Sclerosis

Volumn 15, Issue 7, 2009, Pages 828-833

  Cabrera Gómez, José A ^a   Bonnan, M ^b   Gonzalez Quevedo A ^c,d   Saiz Hinarejos, A ^e   Marignier, R ^f,g   Olindo, S ^b   Graus, F ^e   Smadja, D ^b   Merle, H ^b   Thomas, L ^b   Gomez Garcia A ^h   Cabre, P ^b  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^b Pierre Zobda Quitman Hospital   (Martinique)

^c INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^d University of Barcelona ^*  (Cuba)

^e UNIVERSITY OF BARCELONA   (Spain)

^f HÔPITAL NEUROLOGIQUE   (France)

^g INSERM   (France)

^h Sancti Spiritus Children Hospital Sancti   (Cuba)

Author keywords

Aquaporin 4; Caribbean Basin; Devic's disease; Neuromyelitis IgG antibody; Relapsing neuromyelitis optica

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; INTERFERON; MITOXANTRONE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CARIBBEAN ISLANDS; CONTROLLED STUDY; CUBA; DISEASE SEVERITY; ETHNICITY; FEMALE; FRANCE; GRAY MATTER; HUMAN; IMMUNOASSAY; ITALY; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; PLASMAPHERESIS; PLESIOMORPHY; POPULATION BASED CASE CONTROL STUDY; RACE DIFFERENCE; SERODIAGNOSIS; SPAIN; WHITE MATTER;

EID: 67649311946     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509104585     Document Type: Article

References (25)

1. Wingerchuck, DM, Lennon, V, Pittock, SJ, Luchinetti, CF, Weinshenker, BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
2. Lennon, VA, Wingerchuck, D, Kryzer, T, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
3. Lennon, VA, Kryzer, TJ, Pittock, SJ, Verkman, AS, Hinson, SR. IgG marker of optico-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
4. Jarius, S, Franciotta, D, Bergamaschi, R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007; 68: 1076-1077.
5. Marignier, R, De Seze, J, Vukusic, S, et al. NMO-IgG and Devic's neuromyelitis optica: A French experience. Mult Scler 2008; 14: 440-445.
6. Saiz, A, Zuliani, L, Blanco, Y, Tavolato, B, Giometto, B, Graus, F. Spanish-Italian NMO Study Gruop. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007; 254: 1233-1237 [Epub 2007 Apr 2].
7. Tortorella, C, Ruggieri, M, Zimatore, GB, et al. Blood brain barrier impairment in NMO-IgG seropositive patients: An Aquaporin-4 (AQP-4) related damage? Neurology 2008; 70(Suppl. 1): A-268.
8. Nakashima, I, Fujihara, K, Miyazawa, I, et al. Clinical and MRI features of Japanese MS patients with NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
9. Matsuoka, T, Matsushita, T, Kawano, Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223.
10. Akman-Demir, G, Eraksoy, M, Tuzun, E, et al. Devic's neuromyelitis optica: An analysis of 47 patients and prognostic implications of NMO IgG status. Neurology 2008; 70(Suppl. 1): A-267 [abstract].
11. Pittock, SJ, Lennon, VA, de Seze, J, et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008; 65: 78-83.
12. Misu, T, Fujihara, K, Itoyama, Y. Neuromyelitis optica and anti-aquaporin 4 antibody. An overview. Brain Nerve 2008; 60: 527-537.
13. Banwell, B, Tenembaum, S, Lennon, VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008; 70: 334-335.
14. McKeon, A, Lennon, VA, Lotze, T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
15. Matiello, M, Lennon, VA, Jacob, A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70: 2197-2200 [Epub 2008 Apr 23].
16. Tanaka, K. [Anti-aquaporin 4 antibody in Japanese multiple sclerosis with long spinal cord lesions.] Rinsho Shinkeigaku 2007; 47: 852-854.
17. Cabre, P, Heinzlef, O, Merle, H, et al. Multiple sclerosis and neuromyelitis optica in Martinique. Neurology 2001; 56: 507-514.
18. Cabrera-Gómez, JA, Kurtzke, JF, González-Quevedo, A, Lara-Rodriguez, R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol 2009; doi: 10.1007/s00415-00-0009. [Epub ahead of print].
19. Wingerchuck, DM, Hagancamp, WF, O'Brien, PC, Weinshenker, BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
20. McDonald, WI, Compston, A, Edan, G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of MS. Ann Neurol 2001; 50: 121-127.
21. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
22. Simon, JH, Li, D, Traboulsee, A, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. Am J Neuroradiol 2006; 27: 455-461.
23. Barkhof, F, Filippi, M, Miller, DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
24. Tartaglino, LM, Croul, SE, Planders, AE, et al. Idiopathic acute tranverse myelitis: MR imaging findings. Radiology 1996; 201: 661-669.
25. Pittock, SJ, Lennon, VA, Krecke, K, Wingerchuck, DM, Luchinetti, CF, Weinshenker, BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.